Angular momentum transport modeling: achievements of a gyrokinetic quasi-linear approach

QuaLiKiz, a model based on a local gyrokinetic eigenvalue solver is expanded to include momentum flux modeling in addition to heat and particle fluxes. Essential for accurate momentum flux predictions, the parallel asymmetrization of the eigenfunctions is successfully recovered by an analytical fluid model. This is tested against self-consistent gyrokinetic calculations and allows for a correct prediction of the ExB shear impact on the saturated potential amplitude by means of a mixing length rule. Hence, the effect of the ExB shear is recovered on all the transport channels including the induced residual stress. Including these additions, QuaLiKiz remains ~10 000 faster than non-linear gyrokinetic codes allowing for comparisons with experiments without resorting to high performance computing. The example is given of momentum pinch calculations in NBI modulation experiments

Angular momentum transport modeling: achievements of a gyrokinetic quasi-linear approach

International audienceQuaLiKiz, a model based on a local gyrokinetic eigenvalue solver is expanded to include momentum flux modeling in addition to heat and particle fluxes. Essential for accurate momentum flux predictions, the parallel asymmetrization of the eigenfunctions is successfully recovered by an analytical fluid model. This is tested against self-consistent gyrokinetic calculations and allows for a correct prediction of the E×B shear impact on the saturated potential amplitude by means of a mixing length rule. Hence, the effect of the E×B shear is recovered on all the transport channels including the induced residual stress. Including these additions, QuaLiKiz remains ∼10 000 faster than non-linear gyrokinetic codes allowing for comparisons with experiments without resorting to high performance computing. The example is given of momentum pinch calculations in NBI modulation experiments

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors

BACKGROUND: BI 836880 is a humanized bispecific nanobody® that inhibits vascular endothelial growth factor and angiopoietin-2. Here, we report results from two phase I, nonrandomized, dose-escalation studies (NCT02674152 and NCT02689505; funded by Boehringer Ingelheim) evaluating BI 836880 in patients with confirmed locally advanced or metastatic solid tumors, refractory to standard therapy, or for which standard therapy was ineffective. PATIENTS AND METHODS: Patients aged ≥18 years, with an Eastern Cooperative Oncology Group performance status of 0-2 and adequate organ function received escalating intravenous doses of BI 836880 once every 3 weeks (Q3W; Study 1336.1) or once weekly (QW; Study 1336.6). Primary objectives were maximum tolerated dose (MTD) and recommended phase II dose of BI 836880, based on dose-limiting toxicities (DLTs) during the first cycle. RESULTS: Patients received one of five dosages of 40-1000 mg Q3W (29 patients) or 40-240 mg QW (24 patients). One DLT occurred with Q3W treatment [Grade (G) 3 pulmonary embolism (1000 mg)]. Five DLTs occurred in four patients treated QW [G2 proteinuria (120 mg); G3 hypertension (180 mg); G3 proteinuria and G3 hypertension (240 mg); and G4 respiratory distress (240 mg)]. All patients experienced adverse events, most commonly hypertension with Q3W treatment (89.7%; G3 41.4%), and asthenia with QW treatment (62.5%). Two patients treated Q3W (both 1000 mg) and three patients treated QW (120 mg, 2 patients; 180 mg, 1 patient) experienced partial response. CONCLUSIONS: The MTD of BI 836880 was 720 mg Q3W and 180 mg QW. BI 836880 was generally manageable and demonstrated preliminary efficacy. CLINICAL TRIAL REGISTRATION: ClinicalTrials.govNCT02674152; https://clinicaltrials.gov/ct2/show/NCT02674152 and NCT02689505; https://clinicaltrials.gov/ct2/show/NCT0268950

Transforming chaos to periodic oscillations

We demonstrate that the dynamics of an autonomous chaotic class C laser can be controlled to a periodic state via external modulation of the pump. In the absence of modulation, above the chaos threshold, the laser exhibits Lorenz-like chaotic pulsations. The average amplitude and frequency of these pulsations depend on the pump power. We find that there exist parameter windows where modulation of the pump power extinguishes the chaos in favor of simpler periodic behavior. Moreover we find a number of locking ratios between the pump and laser output follow the Farey sequence